Cigna Investments Inc. New Has $3.14 Million Stock Holdings in Netflix, Inc. (NASDAQ:NFLX)
Cigna Investments Inc. New reduced its stake in Netflix, Inc. (NASDAQ:NFLX – Free Report) by 1.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,428 shares of the Internet television network’s stock after selling 54 shares during the period. Netflix accounts for approximately […]
Cigna Investments Inc. New Cuts Stock Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Cigna Investments Inc. New trimmed its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,671 shares of the pharmaceutical company’s stock after selling 48 shares during the period. […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Holdings Reduced by Cigna Investments Inc. New
Cigna Investments Inc. New cut its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.4% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,087 shares of the biopharmaceutical company’s stock after selling 15 shares during the period. […]
Cigna Investments Inc. New Has $1.66 Million Holdings in RTX Co. (NYSE:RTX)
Cigna Investments Inc. New reduced its position in RTX Co. (NYSE:RTX – Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,686 shares of the company’s stock after selling 216 shares during the quarter. Cigna Investments Inc. […]
Stephens Investment Management Group LLC Has $28.01 Million Holdings in Illumina, Inc. (NASDAQ:ILMN)
Stephens Investment Management Group LLC raised its holdings in shares of Illumina, Inc. (NASDAQ:ILMN – Free Report) by 23.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 214,817 shares of the life sciences company’s stock after purchasing an additional 40,976 shares during […]
last updated on 1 Nov 15:30